Frontline therapy of acute promyelocytic leukemia: Randomized comparison of ATRA and intensified chemotherapy versus ATRA and anthracyclines

Publisher： John Wiley & Sons Inc

E-ISSN： 1600-0609|100|2|154-162

ISSN： 0902-4441

Source： EUROPEAN JOURNAL OF HAEMATOLOGY, Vol.100, Iss.2, 2018-02, pp. : 154-162

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Introducing biological features at diagnosis improves the relapse risk stratification in patients with acute promyelocytic leukemia treated with ATRA and chemotherapy

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 9, 2015-09 ,pp. : E181-E182

John Wiley & Sons Inc

Access to resources Recommend Favorite

Acute promyelocytic leukaemia with t(11;17)(q23;q12‐21) and a good initial response to prolonged ATRA and combination chemotherapy

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 100, Iss. 2, 1998-02 ,pp. : 328-330

John Wiley & Sons Inc

Access to resources Recommend Favorite

Coagulopathy of Acute Promyelocytic Leukemia

By  

Acta Haematologica, Vol. 106, Iss. 1-2, 2001-09 ,pp. : 43-51

Karger

Access to resources Recommend Favorite

Acute Promyelocytic Leukemia with a Smoldering Course Associated with Therapy-Related Myelodysplastic Syndrome

By  

Acta Haematologica, Vol. 126, Iss. 3, 2011-07 ,pp. : 152-156

Karger

Access to resources Recommend Favorite

Comparison of epigenetic versus standard induction chemotherapy for newly diagnosed acute myeloid leukemia patients ≥60 years old

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 7, 2015-07 ,pp. : 639-646

John Wiley & Sons Inc

Access to resources Recommend Favorite